...
首页> 外文期刊>Evidence-based nursing >Review: dietary plus pharmacological intervention (orlistat or sibutramine) induces long term weight loss in overweight or obese adults
【24h】

Review: dietary plus pharmacological intervention (orlistat or sibutramine) induces long term weight loss in overweight or obese adults

机译:综述:饮食加药理干预(奥利司他或西布曲明)可导致超重或肥胖成年人长期体重减轻

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dietary/lifestyle therapy 16 studies (n = 5698) met the selection criteria Mean patient age tanged from 40 to 59 years, and mean weight at baseline ranged from 78 to 116 kg. Dietary/lifestyle interventions comprised very low calorie diets (<1100 kcal/d) or low calorie diets (1200-1500 kcal/d), sometimes combined with behaviour counselling/lifestyle modification. In 13 trials, weight loss was assessed during a 3-18 month induction phase followed up by a 12-36 month weight loss maintenance phase after the intervention In 3 trials, weight loss was assessed only during the 24-48 month induction period Meta-analysis was not done because of study heterogeneity. Weight loss was usually <5 kg after 2-3 years and 1 8-10,0 kg after 4-7 years.
机译:饮食/生活方式疗法16项研究(n = 5698)符合选择标准,平均患者年龄介于40至59岁之间,基线时的平均体重介于78至116 kg之间。饮食/生活方式干预措施包括低卡路里饮食(<1100 kcal / d)或低卡路里饮食(1200-1500 kcal / d),有时与行为咨询/生活方式改变相结合。在13项试验中,在3-18个月的诱导期中评估了体重减轻,随后在干预后进行了12-36个月的减肥维持阶段。在3项试验中,仅在24-48个月的诱导期内评估了体重。由于研究的异质性,未进行分析。 2-3年后体重减轻通常<5 kg,4-7年后体重减轻1 8-10,0 kg。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号